Neuronetics, Inc. Cash Flow Statement
STIM|8 years of annual SEC 10-K data (FY2018-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 8 fiscal years. All figures from audited SEC 10-K filings.
Neuronetics, Inc. used $32M in operating cash flow and negative free cash flow of $34M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.07 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$30.2M | -$37.2M | -$31.2M | -$27.5M | -$29.0M | -$24.1M | -$16.1M | -$11.2M |
| Depreciation & Amortization | $2.0M | $1.6M | $1.1M | $941.0K | $1.1M | $882.0K | $596.0K | $673.0K |
| Operating Cash Flow | -$32.0M | -$30.7M | -$28.0M | -$28.4M | -$30.5M | -$20.6M | -$11.1M | -$8.5M |
| Capital Expenditures | $2.4M | $3.3M | $2.4M | $730.0K | $813.0K | $1.0M | $594.0K | $324.0K |
| Free Cash Flow | -$34.4M | -$34.0M | -$30.3M | -$29.1M | -$31.3M | -$21.6M | -$11.7M | -$8.9M |
| FCF Margin | -48.2% | -52.1% | -54.9% | -59.1% | -50.0% | -40.9% | -92.2% | -25.9% |